ConforMIS Inc. (NASDAQ:CFMS) CTO Daniel Steines sold 10,000 shares of ConforMIS stock in a transaction dated Monday, October 3rd. The stock was sold at an average price of $10.03, for a total value of $100,300.00. Following the completion of the transaction, the chief technology officer now directly owns 225,213 shares of the company’s stock, valued at approximately $2,258,886.39. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Daniel Steines also recently made the following trade(s):
- On Friday, September 16th, Daniel Steines sold 30,000 shares of ConforMIS stock. The stock was sold at an average price of $9.09, for a total value of $272,700.00.
Shares of ConforMIS Inc. (NASDAQ:CFMS) opened at 10.12 on Thursday. The firm’s 50 day moving average price is $8.80 and its 200-day moving average price is $8.80. The company’s market capitalization is $426.33 million. ConforMIS Inc. has a 1-year low of $4.80 and a 1-year high of $23.62.
ConforMIS (NASDAQ:CFMS) last released its quarterly earnings results on Monday, August 8th. The company reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. ConforMIS had a negative return on equity of 45.30% and a negative net margin of 84.33%. The company earned $19.30 million during the quarter, compared to analysts’ expectations of $18.02 million. During the same period last year, the business posted ($2.51) earnings per share. The firm’s revenue was up .5% compared to the same quarter last year. Analysts expect that ConforMIS Inc. will post ($1.40) EPS for the current year.
A number of large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its stake in ConforMIS by 15.1% in the first quarter. Geode Capital Management LLC now owns 77,877 shares of the company’s stock worth $837,000 after buying an additional 10,235 shares during the period. American International Group Inc. boosted its stake in ConforMIS by 242.6% in the second quarter. American International Group Inc. now owns 20,584 shares of the company’s stock worth $144,000 after buying an additional 14,575 shares during the period. Raymond James & Associates acquired a new stake in ConforMIS during the second quarter worth approximately $113,000. Nationwide Fund Advisors boosted its stake in ConforMIS by 276.7% in the second quarter. Nationwide Fund Advisors now owns 22,932 shares of the company’s stock worth $161,000 after buying an additional 16,845 shares during the period. Finally, Oak Ridge Investments LLC acquired a new stake in ConforMIS during the second quarter worth approximately $127,000. Institutional investors own 41.13% of the company’s stock.
Several research firms have recently issued reports on CFMS. B. Riley began coverage on ConforMIS in a research report on Wednesday, September 21st. They issued a “buy” rating and a $13.00 price target for the company. Oppenheimer Holdings Inc. lifted their price target on ConforMIS from $12.00 to $13.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 9th. Zacks Investment Research raised ConforMIS from a “sell” rating to a “hold” rating in a research report on Friday, July 1st. JPMorgan Chase & Co. decreased their target price on ConforMIS from $11.00 to $8.00 and set a “neutral” rating for the company in a research report on Tuesday, August 9th. Finally, SunTrust Banks Inc. began coverage on ConforMIS in a research report on Monday, September 19th. They issued a “buy” rating and a $14.00 target price for the company. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $14.86.
ConforMIS Company Profile
ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.
Receive News & Ratings for ConforMIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.